These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9892851)

  • 21. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.
    Yu VC; Sadée W
    J Pharmacol Exp Ther; 1988 Apr; 245(1):350-5. PubMed ID: 2834542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
    Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T; Wüster M; Gramsch C; Herz A
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divers pathways mediate delta-opioid receptor down regulation within the same cell.
    Shapira M; Keren O; Gafni M; Sarne Y
    Brain Res Mol Brain Res; 2001 Nov; 96(1-2):142-50. PubMed ID: 11731019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delta opioid receptors are involved in morphine-induced inhibition of luteinizing hormone releasing hormone in SK-N-SH cells.
    Bennett L; Ratka A
    Neuropeptides; 2003 Oct; 37(5):264-70. PubMed ID: 14607103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-purity selection and maintenance of gene expression in human neuroblastoma cells stably over-expressing GFP fusion protein. Application for opioid receptors desensitization studies.
    Aguila B; Roussel M; Jauzac P; Allouche S
    Brain Res; 2006 Oct; 1114(1):11-8. PubMed ID: 16938287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Chang SL; Ge LJ; Kastin AJ
    J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
    Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
    Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
    Hjorth SA; Thirstrup K; Schwartz TW
    Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors.
    Ela C; Barg J; Vogel Z; Hasin Y; Eilam Y
    J Mol Cell Cardiol; 1997 Feb; 29(2):711-20. PubMed ID: 9140828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth.
    Hatzoglou A; Bakogeorgou E; Papakonstanti E; Stournaras C; Emmanouel DS; Castanas E
    J Cell Biochem; 1996 Dec; 63(4):410-21. PubMed ID: 8978457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.
    Belcheva MM; Barg J; McHale RJ; Gao XM; Chuang DM; Coscia CJ
    J Pharmacol Exp Ther; 1991 Oct; 259(1):302-9. PubMed ID: 1656025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.